Advertisement
Screener

LivaNova PLC (LIVN) Proceeds from Debt, Maturing in More than Three Months

2.3 / 5 stars · 53/116 Roast Me

LivaNova PLC Proceeds from Debt, Maturing in More than Three Months

LivaNova PLC (LIVN) reported Proceeds from Debt, Maturing in More than Three Months of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-30.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths · last filed 2019-10-30

  • LivaNova PLC proceeds from debt, maturing in more than three months for the quarter ending 2019-09-30 was $0.00.
  • LivaNova PLC proceeds from debt, maturing in more than three months for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
  • LivaNova PLC proceeds from debt, maturing in more than three months for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
  • LivaNova PLC proceeds from debt, maturing in more than three months for the quarter ending 2018-12-31 was $0.00.
  • LivaNova PLC proceeds from debt, maturing in more than three months for fiscal 2018 was $240.00M, a 1100.00% increase from fiscal 2017.
  • LivaNova PLC proceeds from debt, maturing in more than three months for fiscal 2017 was $20.00M.
  • LivaNova PLC proceeds from debt, maturing in more than three months for fiscal 2016 was $0.00.
Period endProceeds from Debt, Maturing in More than Three Months 3 monthProceeds from Debt, Maturing in More than Three Months 6 monthProceeds from Debt, Maturing in More than Three Months 9 monthProceeds from Debt, Maturing in More than Three Months 12 month
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$0.00
derived: sum of 2 quarters · filed 2019-10-30
$0.00
10-Q · filed 2019-10-30
$0.00
derived: sum of 4 quarters · filed 2019-10-30
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$0.00
10-Q · filed 2019-07-31
$0.00
derived: sum of 3 quarters · filed 2019-07-31
$0.00
derived: sum of 4 quarters · filed 2019-10-30
2019-03-31$0.00
10-Q · filed 2019-05-01
$0.00
derived: sum of 2 quarters · filed 2019-05-01
$0.00
derived: sum of 3 quarters · filed 2019-10-30
$220.00M
derived: sum of 4 quarters · filed 2019-10-30
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$0.00
derived: sum of 2 quarters · filed 2019-10-30
$220.00M
derived: sum of 3 quarters · filed 2019-10-30
$240.00M
10-K · filed 2019-03-18
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$220.00M
derived: sum of 2 quarters · filed 2019-10-30
$240.00M
10-Q · filed 2019-10-30
2018-06-30$220.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$240.00M
10-Q · filed 2019-07-31
2018-03-31$20.00M
10-Q · filed 2019-05-01
2017-12-31$20.00M
10-K · filed 2019-03-18
2016-12-31$0.00
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53